Delivery Order SPE2DB20D1109-SPE2DB25FP85H
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) on September 2, 2025, with a ceiling value of $2,667.56 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.98 to AmerisourceBergen Drug Corp for NEXLETOL 180 mg tablets (30-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NEXLETOL is a non-statin, non-ezetimibe medication used to manage cholesterol levels in patients with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.72 for NEXLETOL 180 mg tablets (30-count units) with an ultimate completion date of July 11, 2025. This is a firm fixed-price, non-set-aside contract performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $2,172.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) with an ultimate completion date of September 24, 2025. This non-set-aside award was issued on September 23, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Nexletol 180 mg tablets (30-count units) with a contract ceiling value of $1,216.14. This firm fixed-price delivery order, which carries an ultimate completion date of June 6, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,988.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,068.11 by the Defense Logistics Agency (DLA) on July 11, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 14, 2025, and represents a child award under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical distributor will fulfill...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 mg Nexletol tablets, a medication used to treat high cholesterol. The contract has a ceiling value of $1,030.70 and a completion date of June 26, 2025. It is a Firm Fixed Price contract, meaning the price is set and will not change. The contract is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nexletol 180 mg tablets (30-unit packaging) valued at $1,389.23. This competitively awarded, firm fixed-price delivery order is non-set-aside and has a completion date of July 31, 2025. The award is issued to AmerisourceBergen Drug Corp's Corporate Office, with performance taking place at the company's Conshohocken, Pennsylvania headquarters, which serves as a major hub for...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,196.33 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide NEXLETOL 180 MG TABLET medical products. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which supplies a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP85HDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,248.36 to AmerisourceBergen Drug Corp for the supply of Nexletol 180 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nexletol is a prescription medication used to manage cholesterol levels in patients with cardiovascular disease risk factors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs for military and veteran healthcare systems through this framework contract, which enables the company to supply a broad range of pharmaceutical products and medical commodities to support Department of Defense healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/26/25 |